Every trade that managers of MedX Health Corp. disclose to SEDI is tracked on this page. The company sits in the Health Care sector. The last twelve months, up to 24 October 2026, brought 8 filings signed by 3 insiders.
Not one open-market sale was filed. On the buying side, 2 insiders reported 2 purchases totalling €23k. Unlike grants, an open-market purchase is paid for by the insider, at the market price. On the buying side, the filings list 2 senior executives among the declarants. The largest single trade was a purchase of €14k by Hennigar, David John, published on 13 March 2026.
For context, the typical company on the same exchange (median of 2,734 companies) published 14 filings over the same period, against 8 filings here. Since 2016, the database holds 28 purchases and 12 sales by insiders of the company.
The last insider purchase was made public on 31 March 2026, 208 days ago. Most trades are made public on the day they happen. Until a filing is published, the market cannot know about the trade.
In the same sector, recent insider purchases at Dynavox Group AB and EssilorLuxottica also feature in our signals. These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
FY ended December 2025 · cache
25 of 82 declarations
MedX Health Corp. is a company focused on developing digital health solutions. It aims to enhance patient care through innovative technologies.
Purchases our model currently ranks for the recommendations list.
All recommendationsInsider filings
Over the last 90 days, 5 filings published between 10 August and 20 October 2026: no open-market purchase or sale filed by an insider. 5 other filings (not open-market purchases or sales: grants, options, plans, sale notices, block transfers).
Summary written automatically from public filings, without human review. General information, identical for every reader: it is not investment advice or a recommendation to buy or sell. Investing involves a risk of capital loss. Generated on 21 October 2026 (UTC)